News
Katie Price has spoken about reaching out to her son Harvey's half-brother, Orlando Yorke, and how she couldn't believe how ...
Discover key insights from Soleno Therapeutics' Q2 2025 earnings call, highlighting Vykat XR's strong launch, revenue growth, EU expansion efforts & ...
New approach finds ‘parent-of-origin’ effects in more than a dozen genes — without the need for parental data.
Announced submission and validation of Marketing Authorization Application (MAA) submission to the European Medicines Agency (EMA) seeking marketing approval of DCCR (marketed in the U.S. as VYKAT XR) ...
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced its financial results for the second quarter ended June 30, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results